Form 8-K - Current report:
SEC Accession No. 0001493152-24-049874
Filing Date
2024-12-13
Accepted
2024-12-13 06:06:57
Documents
60
Period of Report
2024-12-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41607
2 ex99-1.htm EX-99.1 43726
3 form8-k_001.jpg GRAPHIC 5681
4 ex99-1_001.jpg GRAPHIC 1434165
5 ex99-1_002.jpg GRAPHIC 2573441
6 ex99-1_003.jpg GRAPHIC 1901876
7 ex99-1_004.jpg GRAPHIC 2005383
8 ex99-1_005.jpg GRAPHIC 1388130
9 ex99-1_006.jpg GRAPHIC 1863283
10 ex99-1_007.jpg GRAPHIC 2068183
11 ex99-1_008.jpg GRAPHIC 1938833
12 ex99-1_009.jpg GRAPHIC 1995160
13 ex99-1_010.jpg GRAPHIC 2031934
14 ex99-1_011.jpg GRAPHIC 2013335
15 ex99-1_012.jpg GRAPHIC 1578156
16 ex99-1_013.jpg GRAPHIC 1564224
17 ex99-1_014.jpg GRAPHIC 1353242
18 ex99-1_015.jpg GRAPHIC 1887165
19 ex99-1_016.jpg GRAPHIC 2398583
20 ex99-1_017.jpg GRAPHIC 1675256
21 ex99-1_018.jpg GRAPHIC 1753542
22 ex99-1_019.jpg GRAPHIC 2169503
23 ex99-1_020.jpg GRAPHIC 2032913
24 ex99-1_021.jpg GRAPHIC 2030377
25 ex99-1_022.jpg GRAPHIC 1527586
26 ex99-1_023.jpg GRAPHIC 1712057
27 ex99-1_024.jpg GRAPHIC 1505062
28 ex99-1_025.jpg GRAPHIC 1423531
29 ex99-1_026.jpg GRAPHIC 2058916
30 ex99-1_027.jpg GRAPHIC 2007571
31 ex99-1_028.jpg GRAPHIC 2157109
32 ex99-1_029.jpg GRAPHIC 1429229
33 ex99-1_030.jpg GRAPHIC 2684933
34 ex99-1_031.jpg GRAPHIC 1746080
35 ex99-1_032.jpg GRAPHIC 1992941
36 ex99-1_033.jpg GRAPHIC 1459244
37 ex99-1_034.jpg GRAPHIC 2145595
38 ex99-1_035.jpg GRAPHIC 1890322
39 ex99-1_036.jpg GRAPHIC 2191083
40 ex99-1_037.jpg GRAPHIC 1361757
41 ex99-1_038.jpg GRAPHIC 1942179
42 ex99-1_039.jpg GRAPHIC 1633826
43 ex99-1_040.jpg GRAPHIC 1364244
44 ex99-1_041.jpg GRAPHIC 1687812
45 ex99-1_042.jpg GRAPHIC 1131258
46 ex99-1_043.jpg GRAPHIC 1580481
47 ex99-1_044.jpg GRAPHIC 1911332
48 ex99-1_045.jpg GRAPHIC 1897770
  Complete submission text file 0001493152-24-049874.txt   112968413

Data Files

Seq Description Document Type Size
49 XBRL SCHEMA FILE lpcn-20241213.xsd EX-101.SCH 3015
50 XBRL LABEL FILE lpcn-20241213_lab.xml EX-101.LAB 34240
51 XBRL PRESENTATION FILE lpcn-20241213_pre.xml EX-101.PRE 24165
62 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3685
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 241546653
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)